Search the Newsreel

Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price

Canaccord Genuity Group has increased its price target for Biodesix (NASDAQ:BDSX) to $35 from $27, maintaining a "buy" rating and implying a significant upside of 48.94%. This positive forecast aligns with a "Moderate Buy" consensus rating from other analysts, supported by the company's recent …

Canaccord raises Biodesix stock price target on strong test volume

Canaccord has increased its price target for Biodesix Inc. (NASDAQ:BDSX) to $35 from $27, maintaining a Buy rating, due to higher revenue projections for 2026 and beyond. This adjustment follows Biodesix's strong second-quarter 2026 results, which surpassed estimates, driven by increased Nodify test volume …

California State Teachers Retirement System Purchases 10,579 Shares of Diodes Incorporated $DIOD

The California State Teachers Retirement System increased its stake in Diodes Incorporated (NASDAQ:DIOD) by 23.8% in the first quarter, acquiring an additional 10,579 shares to a total of 54,987 shares valued at $3.75 million. This semiconductor company has 99.23% institutional ownership and reported strong …

Diodes Incorporated (DIOD) Stock Forecasts

Argus has raised its target price for Diodes Incorporated (DIOD) to $93.00. The company manufactures and supplies high-quality application-specific products in the semiconductor markets. This report suggests a positive outlook for DIOD stock.

(ANGO) Price Dynamics and Execution-Aware Positioning

This article from Stock Traders Daily provides an AI-driven analysis of Angiodynamics Inc. (NASDAQ: ANGO), highlighting strong sentiment across all horizons and significant upside potential due to a lack of resistance levels. It outlines three distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk …

Earnings Update: Here's Why Analysts Just Lifted Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$32.67

Biodesix, Inc. (NASDAQ:BDSX) recently released its quarterly results, showing better-than-expected revenues of US$27m and smaller statutory losses of US$0.71 per share. Following these results, analysts have updated their forecasts for 2026, predicting revenues of US$111.5m and reduced losses per share. This positive outlook has …

Diodes Incorporated Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

AngioDynamics, Inc. (ANGO) stock price, news, quote and history

This article provides comprehensive financial information for AngioDynamics, Inc. (ANGO), including its current stock price, trading activity, key financial metrics, and an overview of its medical technology products. It also features performance comparisons against the S&P 500, earnings trends, analyst ratings, and a list …

Biodesix Inc (BDSX) Stock News Today

Biodesix (BDSX) Stock Pullback Puts Focus On Losses Despite Stronger Margins

Biodesix (BDSX) stock saw a nearly 3% pullback despite reporting a narrowed net loss of US$7.3m and a strong gross margin of 82% in Q2 2026. While revenue increased by 34% year-over-year, the market focused on the company's continued losses, raising questions about whether …

Biodesix boosts sales, trims loss as diagnostics firm pushes toward profitability

Biodesix Inc. (Nasdaq: BDSX) reported improved top and bottom lines in the second quarter, indicating progress towards profitability. The life-sciences company, which specializes in lung diagnostic tools, has shown consistent efforts to boost sales and reduce losses. This financial improvement positions Biodesix on a …

Diodes (DIOD) Is Up 27.8% After AI-Auto Strength, Q3 Outlook And Buyback Progress - What's Changed

Diodes Incorporated (DIOD) reported strong Q2 2026 results driven by AI infrastructure and automotive electronics demand, leading to a 27.8% stock increase. The company provided Q3 2026 revenue guidance of approximately US$510 million and updated its share repurchase program progress. This performance is reshaping …

Can Diodes (DIOD) Justify Its Valuation As Earnings And Guidance Impress?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. What Diodes' latest earnings event means for investors Diodes (DIOD) just reported second quarter 2026 results alongside fresh third quarter guidance, giving you new …

State Street Corporation (DIOD) reports 5.7% beneficial stake in Diodes Inc

State Street Corporation has reported a beneficial ownership of 5.7% in Diodes Inc., amounting to 2,605,247 shares as of June 30, 2026. These shares are managed on behalf of clients through State Street's asset management entities, with all shares carrying shared dispositive power and …

Diodes (DIOD) Stock Looks Fully Priced After A 109% Run

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Diodes stock has delivered a strong 1 year return, yet the current valuation checks …

AngioDynamics SmartPort Infection Lawsuit Alleges Defective Port Caused Sepsis

A Pennsylvania man has filed a lawsuit against AngioDynamics and Navilyst Medical, alleging that a defective SmartPort catheter caused a severe infection and sepsis, necessitating its surgical removal. The complaint claims that defects in the port catheter promoted bacterial growth and that the companies …

Biodesix, Inc. Stock 12‑Month Price Target Raised to $32.67, Implies 43% Upside

Biodesix, Inc. (BDSX) has seen its average 12-month price target increased by analysts from $30.83 to $32.67, suggesting a potential 43% upside based on the Aug. 5 closing price. The consensus rating from 7 analysts remains a "Buy," with all seven recommending the stock.

Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

AngioDynamics (ANGO) faces a trade-off between its rapidly expanding Med Tech platforms and persistent margin pressure from tariffs and rising operating costs. While NanoKnife, Auryon, and AlphaVac show strong growth potential and strategic importance, the company's valuation is mixed, and a Zacks Rank #4 …

ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus

AngioDynamics, Inc. ANGO has set an initial fiscal 2027 framework that keeps its Med Tech transformation at the center of the investment case. Faster growth from its priority platforms is expected to lift sales, but margin pressure and continued losses remain material constraints. The …

ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?

AngioDynamics (ANGO) shares have significantly outperformed the market, gaining 33.5% in three months, driven by its shift towards higher-margin Med Tech platforms like NanoKnife and Auryon. While Med Tech growth and product differentiation support the company's momentum, concerns about valuation, tariff impact on earnings …

FMR LLC reports 9.5% Diodes Inc (DIOD) ownership in amended 13G

FMR LLC and Abigail P. Johnson have reported a 9.5% passive beneficial ownership stake in Diodes Inc (DIOD) through an amended Schedule 13G filing. FMR LLC holds sole voting power over 4,360,131.00 shares and sole dispositive power over 4,380,124.40 shares, while Abigail P. Johnson …

Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks M

Zacks Research Reduces Earnings Estimates for AngioDynamics

Biodesix, Inc. Reports Impairment Loss on Intangible Assets for the Second Quarter Ended June 30, 2026

Biodesix, Inc. announced an impairment loss on intangible assets for the second quarter ended June 30, 2026. The reported impairment loss was $12,000, a decrease from $26,000 in the same period last year. This information was released on August 5, 2026, as part of …

Diodes anticipates Q3 revenue of about $510M with 35% gross margin as it advances proposed ElevATE deal

Earnings Call Insights: Diodes Incorporated (DIOD) Q2 2026 MANAGEMENT VIEW * Gary Yu (President, CEO & Director) said the company “extend[ed] our momentum in the second quarter with revenue again increasing more than 20% year-over-year” and added that revenue “increased 10% sequentially, coupled with …

Diodes Incorporated 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:DIOD) 2026-08-06

Diodes (NASDAQ:DIOD) Shares Gap Up on Strong Earnings

Earnings Flash (DIOD) Diodes Incorporated Reports Q2 Revenue $445.5M, Vs. FactSet Est of $436.6M

Diodes Incorporated (DIOD) announced its second-quarter revenue of $445.5 million, surpassing FactSet's estimate of $436.6 million. This flash earnings report highlights the company's financial performance relative to analyst expectations for the quarter.

Diodes Inc. Q2 2026: Revenue $445.5M, EPS $1— 10-Q Summary

Diodes Inc. reported its second-quarter 2026 financial results, showing revenue of $445.5 million and diluted EPS of $1. The company saw a 21.7% year-over-year increase in revenue, primarily driven by a 24.8% increase in volume. Strategic highlights include strengthening demand in the computing/AI server …

Diodes Q2 Earnings Call Highlights

Key Points Interested in Diodes Incorporated? Here are five stocks we like better. Diodes reported strong second-quarter growth: Revenue rose 22% year over year to $445.5 million, while adjusted EPS more than doubled to $0.70. Gross margin improved to 33.1%, supported by cost and …

Diodes Inc (DIOD) Shares Fall 3.1% -- GF Value Says Still Overva

Diodes Inc (DIOD) shares fell 3.1% to $85.74, placing it 23.8% above its fair value estimate of $69.27 according to GF Value™, indicating it is overvalued. The company has a GF Score™ of 70/100, showing good financial strength and momentum but weak growth, while …

Diodes (NASDAQ:DIOD) Announces Quarterly Earnings Results

Diodes (NASDAQ:DIOD) reported strong Q2 earnings, exceeding analyst expectations with an EPS of $0.70 and revenue of $445.5 million, marking a 22% year-over-year increase. The company's growth is attributed to record automotive sales and increasing demand from AI servers and data centers, with management …

Diodes (NASDAQ:DIOD) Releases Q3 2026 Earnings Guidance

Biodesix, Inc. (BDSX) Reports Q2 Loss, Beats Revenue Estimates

Biodesix, Inc. (BDSX) reported a Q2 loss of $0.71 per share, which beat the Zacks Consensus Estimate of a $0.86 loss, marking a 17.44% surprise. The company's revenues for the quarter reached $26.86 million, exceeding estimates by 2.92% and showing growth from $20.02 million …

BIODESIX ($BDSX) Releases Q2 2026 Earnings

Biodesix Inc (NASDAQ:BDSX) is scheduled to release its Q2 2026 earnings on August 5, 2026, with analysts expecting revenue of $26.03 million and earnings of -$0.91 per share. GuruFocus indicates a 6.22% upside based on its GF Value, while analysts have an average target …

Diodes Incorporated Reports Second Quarter 2026 Financial Results

Extends Growth Momentum in 2Q with Revenue Increasing over 20% and non-GAAP EPS Up over 100% YoY PLANO, Texas, August 05, 2026--(BUSINESS WIRE)--Diodes Incorporated (Diodes) (Nasdaq: DIOD) today reported its financial results for the second quarter ended June 30, 2026. Second Quarter Highlights Revenue …